I would be happier sooner than later


regarding one aspect of leronlimab, Cytodyn, it’s strategy and its tactics.

Dr. Pourhassan has been incredibly successful resuscitating Cytodyn, and by his actions, potentially saving many millions of lives.

Nonetheless, that does not mean he is the right person to continue as CEO perpetually.

At some point Dr. Pourhassan will want to step back and admire what he has created or his board will decide someone else should take the helm.